This is in line with reports that 66–100% of tumors in BRCA1 mutation carriers exhibit grade 3 histology compared to 16–57% and 15–55% of disease in BRCA2 carriers and sporadic breast cancers, respectively24. The gene discussed is BRCA2; the disease is breast cancer.